Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]

First- and second-line treatments for locally advanced renal cell carcinoma

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

First- and second-line treatments for locally advanced renal cell carcinoma ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

Emerging management of metastatic castration-sensitive prostate cancer: front...

Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA

Emerging management of metastatic castration-sensitive prostate cancer: front-line chemotherapy vs. oral therapy ( Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA )

Highlights from IGILUC 2019

Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt

Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )

Quality of life and local treatment of oligometastatic prostate cancer

Prof Claude Abbou - Clinique de l'Alma, Paris, France

Quality of life and local treatment of oligometastatic prostate cancer ( Prof Claude Abbou - Clinique de l'Alma, Paris, France )

Challenges in the treatment of upper urinary tract tumours

Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK

Challenges in the treatment of upper urinary tract tumours ( Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK )

PARP inhibitors and their side effects in solid tumour therapy

Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA

PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )

Challenges to Jordanian Muslim men with prostate cancer

Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand

Challenges to Jordanian Muslim men with prostate cancer ( Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand )

5' UTR mutations in prostate cancer

Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA

5' UTR mutations in prostate cancer ( Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA )

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1...

Dr James Gulley - National Cancer Institute, Bethesda, USA

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )

Risk factors for prostate cancer in men of African descent

Dr Faruk Mohammed - Ahmadu Bello University, Zaria, Nigeria

Risk factors for prostate cancer in men of African descent ( Dr Faruk Mohammed - Ahmadu Bello University, Zaria, Nigeria )

GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration...

Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas...

GU Debates 2019: Changing treatment paradigms for hormone-naïve and castration-resistant prostate cancer (1/2) ( Dr Eleni Efstathiou, Prof Peter Goebell, Prof Joaquim Bellmunt, Prof Thomas Steuber )

GU Debates 2019: Practice-changing developments in urothelial cancer (2/2)

GU Debates 2019: Practice-changing developments in urothelial cancer (2/2) ( )

More from ecancer